Sonoma Pharmaceuticals (SNOA) Misses Q4 EPS by 33c

Sonoma Pharmaceuticals (NASDAQ: SNOA) reported Q4 EPS of ($0.33). Revenue for the quarter came in at $5.56 million.

For earnings history and earnings-related data on Sonoma Pharmaceuticals (SNOA) click here.

You May Also Be Interested In

• Eagle Financial Services, Inc. (EFSI) Misses Q2 EPS by 38c
• Berenberg Starts Bridgepoint Group PLC (BPT:LN) at Buy
• Boston Beer Co. (SAM) Misses Q2 EPS by 131c ; Offers Guidance